ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
DENOSUMABUM
Active substance (INN) · ATC M05BX04 · 18 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| M003M | OSTEOPOROZA - ACIDUM ALENDRONICUM**; ACIDUM RISEDRONICUM**; ACIDUM ZOLENDRONICUM**; COMBINAŢII (ACIDUM ALENDRONICUM + COLECALCIFEROLUM)**; DENOSUMABUM(Prolia)**; TERIPARA… | In force | medicine of the protocol | C2-P7(eliberare prin farmaciile cu circuit inchis ale unitatilor sanitare cu paturi prin care se deruleaza programul) | NO |
| M05BX04 | DENOSUMAB (60 mg/ml) | In force | medicine of the protocol | C1-G22 | NO |
| M05BX04-ONCO | DENOSUMAB | In force | medicine of the protocol | C2-P3 | NO |
| L01EM03 | ALPELISIB | In force | mentioned in the text | C2-P3 | YES |
| M01AE52 | COMBINATII(NAPROXENUM+ESOMEPRAZOLUM) | In force | mentioned in the text | B | YES |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| DENBRAYCE 120 mg | SOL. INJ. | 70mg/ml | MABXIENCE RESEARCH SL - SPANIA | M05BX04 | PR |
| ENWYLMA 120 mg | SOL INJ. | 70mg/ml | ZENTIVA K.S. - REPUBLICA CEHA | M05BX04 | PR |
| JUBBONTI 60 mg | SOL INJ. IN SERINGA PREUMPLUTA | 60mg/ml | SANDOZ GMBH - AUSTRIA | M05BX04 | PRF |
| JUBEREQ 120 mg | SOL INJ. | 70mg/ml | ACCORD HEALTHCARE S.L.U. - SPANIA | M05BX04 | PR |
| JUNOD 60 mg | SOL INJ. IN SERINGA PREUMPLUTA | 60mg/ml | GEDEON RICHTER PLC. - UNGARIA | M05BX04 | PRF |
| KEFDENSIS 60 mg | SOL INJ. IN SERINGA PREUMPLUTA | 60mg/ml | STADA ARZNEIMITTEL AG - GERMANIA | M05BX04 | PRF |
| OBODENCE 60 mg | SOL INJ. IN SERINGA PREUMPLUTA | 60mg/ml | SAMSUNG BIOEPIS NL B.V. - OLANDA | M05BX04 | PRF |
| OSENVELT 120 mg | SOL INJ. | 70mg/ml | CELLTRION HEALTHCARE HUNGARY KFT. - UNGARIA | M05BX04 | PR |
| OSVYRTI 60 mg | SOL INJ. IN SERINGA PREUMPLUTA | 60mg/ml | ACCORD HEALTHCARE S.L.U. - SPANIA | M05BX04 | PRF |
| PROLIA | SOL. INJ. IN SERINGA PREUMPLUTA | 60mg/ml | AMGEN EUROPE B.V. - OLANDA | M05BX04 | PRF |
| STOBOCLO 60 mg | SOL INJ. IN SERINGA PREUMPLUTA | 60mg/ml | CELLTRION HEALTHCARE HUNGARY KFT. - UNGARIA | M05BX04 | PRF |
| WYOST 120 mg | SOL INJ. | 70mg/ml | SANDOZ GMBH - AUSTRIA | M05BX04 | PR |
| XBRYK 120 mg | SOL INJ. | 70mg/ml | SAMSUNG BIOEPIS NL B.V. - OLANDA | M05BX04 | PR |
| XGEVA 120 mg | SOL. INJ. IN SERINGA PREUMPLUTA | 120mg/ml | AMGEN EUROPE B.V. - OLANDA | M05BX04 | PR |
| XGEVA 120mg | SOL. INJ. | 70mg/ml | AMGEN EUROPE B.V. - OLANDA | M05BX04 | PR |
| YAXWER 120 mg | SOL INJ. | 70mg/ml | GEDEON RICHTER PLC. - UNGARIA | M05BX04 | PR |
| ZADENVI 60 mg | SOL INJ. IN SERINGA PREUMPLUTA | 60 mg/ml | ZENTIVA K.S. - REPUBLICA CEHA | M05BX04 | PRF |
| ZVOGRA 120 mg | SOL INJ. | 70mg/ml | STADA ARZNEIMITTEL AG - GERMANIA | M05BX04 | PR |